ABL Diagnostics S. A. These solutions are designed for molecular detection by Polymerase Chain Reaction (PCR) through their UltraGene® technology and for genotyping through DNA sequencing using DeepChek®.

These cutting-edge technologies allow for precise identification of genomic variations such as single nucleotide polymorphisms (SNP), amino-acid mutations, and variants of concern. ABL Diagnostics covers a wide range of applications in microbiology, with a primary focus on HIV, SARS-CoV-2, tuberculosis, viral hepatitis B and C, and microbiome analyses. With a comprehensive portfolio of CE-IVD marked assays and kits, ABL Diagnostics generates recurring revenue and is committed to meeting the evolving needs of the market.

Their products are marketed globally through their own sales team and a network of exclusive distributors. ABL Diagnostics serves academic clinical pathology labs, private reference labs, and researchers who are looking to implement innovative and robust microbiology solutions. Contact ABL Diagnostics for further information on the registration status of their products in your territory